Epigenomic manipulation reveals the relationship between locus specific chromatin dynamics and gene expression

Vrinda Venu,Eric M. Small,Cullen Roth,Samantha H. Adikari,Anna Hendrika Cornelia Vlot,Kyle A Sullivan,Chanaka Roshan Abeyratne,Daniel Jacobson,Shawn R. Starkenburg,Karissa Y. Sanbonmatsu,Christina R. Steadman

DOI: https://doi.org/10.1101/2024.07.17.603961

2024-07-19

Abstract:Dysregulation of epigenetic processes leads to a plethora of abnormalities including disease states such as cancer. Therapies focused on epigenetic modulation alter gene expression to correct dysfunction, though the mechanisms and perpetuation of these states is unknown. Here, we use integrated epigenomics and three-dimensional chromatin structure-function analyses after acute histone deacetylase inhibitor cancer drug treatment (suberoylanilide hydroxamic acid in lung cancer cells). Treatment induced substantial (13%) genomic rearrangement that rebounds despite persistent gene expression changes and spreading of acetylation. The chromatin functional landscape (accessibility, active transcription modification, and gene expression) is controlled and locus-specific, while chromatin contacts are globally altered resulting in a moderate weakening of topologically associating domains. Chromatin states are more dynamic at transcriptionally active loci while genes with reduced expression are epigenetically stable suggesting chromatin architectural turnover and nucleosome remodeling is locus-specific and underlies the bidirectional expression changes. Thus, local 3D chromatin and genome structural dynamics is integral for loci regulation in response to epigenomic perturbation. The partial persistence of these altered features may have larger implications for efficacy of epigenetic drugs in amelioration of disease states.

Biology